XML 46 R35.htm IDEA: XBRL DOCUMENT
v3.25.3

COMMON STOCK PURCHASE WARRANTS (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Common Stock Purchase Warrants |
SCHEDULE OF WARRANT ACTIVITY | The following table summarizes information about shares issuable under warrants outstanding during the nine months ended September 30, 2025 and 2024: SCHEDULE OF WARRANT ACTIVITY
|  | Warrants |  |  | Weighted average exercise price |
Balance, January 1, 2025 |  |  | 5,448 |  |  | $ | 1,900.00 |
Issuance February 2025 – Prefunded Warrants |  |  | 49,075 |  |  |  | 0.001 |
Issuance/activation of February 2025 – Series A Warrants |  |  | 347,796 |  |  |  | 62.00 |
Issuance of September 2025 – Detachable Warrants |  |  | 476,569 |  |  |  | 2.124 |
Issuance/activation of February 2025 – Series B Warrants |  |  | 1,669,357 |  |  |  | — |
Exercise February 2025 – Prefunded Warrants |  |  | (49,075 | ) |  |  | 0.001 |
Exercised June 2024 - Series B warrants |  |  | (1,897 | ) |  |  | 0.001 |
Exercised February 2025 – Series B Warrants |  |  | (1,669,320 | ) |  |  | — |
Terminated/Cancelled |  |  | — |  |  |  | — |
Balance, September 30, 2025 |  |  | 827,953 |  |  | $ | 171.22 |
|  | Warrants |  |  | Weighted average exercise price |
Balance, January 1, 2024 |  |  | 563 |  |  | $ | 13,000.00 |
Issued |  |  | 884 |  |  |  | 5,020.00 |
Exercised |  |  | — |  |  |  | — |
Terminated/Cancelled |  |  | — |  |  |  | — |
Balance, September 30, 2024 |  |  | 1,447 |  |  | $ | 8,120.00 |
SCHEDULE OF RANGE OF EXERCISE PRICES AND WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF WARRANTS | The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable warrants to purchase shares of Common Stock as of September 30, 2025: SCHEDULE OF RANGE OF EXERCISE PRICES AND WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF WARRANTS
|  |  | Outstanding and exercisable warrants |
Exercise price |  |  | Number of warrants |  |  | Weighted average remaining contractual life |
$ | — |  |  |  | 37 |  |  |  | 2.1 years |
$ | 2.124 |  |  |  | 476,569 |  |  |  | 5.0 years |
$ | 62.00 |  |  |  | 347,796 |  |  |  | 4.6 years |
$ | 1,004.00 |  |  |  | 2,989 |  |  |  | 3.7 years |
$ | 11,000,00 |  |  |  | 188 |  |  |  | 2.5 years |
$ | 13,000.00 |  |  |  | 188 |  |  |  | 2.5 years |
$ | 15,000.00 |  |  |  | 186 |  |  |  | 2.5 years |
|  |  |  |  | 827,953 |  |  |  | 4.8 years |
SCHEDULE OF WARRANT MODIFICATION | SCHEDULE OF WARRANT MODIFICATION
|  | Pre funded warrants issuance date – February 13, 2025 assumptions |
Volatility – range |  |  | 110.1 | %
Risk-free rate |  |  | 4.27 | %
Dividend |  |  | — | %
Remaining contractual term |  |  | 0.03 years |
Exercise price |  | $ | 0.001 |
Common stock issuable under the warrants |  |  | 49,075 |
|  | Series A warrants issuance/activation date – May 6, 2025 assumptions |
Volatility – range |  |  | 158.07 | %
Risk-free rate |  |  | 3.87 | %
Dividend |  |  | — | %
Remaining contractual term |  |  | 5.0 years |
Exercise price |  | $ | 62.00 |
Common stock issuable under the warrants |  |  | 347,796 |
|  | Series A warrants transition date – June 27, 2025 assumptions |
Volatility – range |  |  | 154.71 | %
Risk-free rate |  |  | 3.79 | %
Dividend |  |  | — | %
Remaining contractual term |  |  | 4.86 years |
Exercise price |  | $ | 62.00 |
Common stock issuable under the warrants |  |  | 347,796 |
|  | Series B warrants issuance/activation date – May 6, 2025 assumptions |
Volatility – range |  |  | 195.04 | %
Risk-free rate |  |  | 3.87 | %
Dividend |  |  | — | %
Remaining contractual term |  |  | 2.5 years |
Exercise price |  | $ | 0.00 |
Common stock issuable under the warrants |  |  | 1,669,357 |
|  | Series B issuance date - December 17, 2024 assumptions |  |  | Series B - December 31, 2024 assumptions |
Volatility – range |  |  | 105.5 | % |  |  | 105.7 | %
Risk-free rate |  |  | 4.26 | % |  |  | 4.38 | %
Dividend |  |  | — | % |  |  | — | %
Remaining contractual term |  |  | 4.5 years |  |  |  | 4.48 years |
Exercise price |  | $ | 0.001 |  |  | $ | 0.001 |
Common stock issuable under the warrants |  |  | 238,339 |  |  |  | 189,689 |
|  | Issuance date assumptions |  |  | December 31, 2024 assumptions |  |  | September 30, 2025 assumptions |
Volatility – range |  |  | 72.1 - 101.1 | % |  |  | 105.7 | % |  |  | 151.59 | %
Risk-free rate |  |  | 4.25 – 5.46 | % |  |  | 4.38 | % |  |  | 3.68 | %
Dividend |  |  | — | % |  |  | — | % |  |  | — | %
Remaining contractual term |  |  | 0.1-5.0 years |  |  |  | 4.5 years |  |  |  | 3.7 years |
Exercise price |  | $ | 5,020.00 |  |  | $ | 1,004.00 |  |  |  | 1,004.00 |
Common stock issuable under the warrants |  |  | 884 |  |  |  | 2,989 |  |  |  | 2,989 |
|  | December 31, 2024 assumptions |  |  | September 30, 2025 assumptions |
Volatility – range |  |  | 109.5 | % |  |  | 151.59 | %
Risk-free rate |  |  | 4.38 | % |  |  | 3.68 | %
Dividend |  |  | — | % |  |  | — | %
Remaining contractual term |  |  | 3.3 years |  |  |  | 2.5 years |
Exercise price |  |  | 11,000.00 – 15,000.00 |  |  |  | 11,000.00 – 15,000.00 |
Common stock issuable under the warrants |  |  | 562 |  |  |  | 562 |

X
- References No definition available. + Details
Name: | DGLY_DisclosureCommonStockPurchaseWarrantsAbstract
Namespace Prefix: | DGLY_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of range of exercise prices and weighted average remaining contractual life of warrants [TableTextBlock] + References No definition available. + Details
Name: | DGLY_ScheduleOfRangeOfExercisePricesAndWightedAverageRemainingContractualLifeOfWarrantsTableTextBlock
Namespace Prefix: | DGLY_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of Warrant Modification [Table Text Block] + References No definition available. + Details
Name: | DGLY_ScheduleOfWarrantModificationTableTextBlock
Namespace Prefix: | DGLY_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration